Fundraising Fox

Shoulder Innovations

NYSE: SI

Northern California, US · Founded 2015 · Delaware corporation · 9 known investors

shoulderinnovations.com ↗

Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis. The company produces medical devices for orthopedic shoulder procedures.

HardwareHealthtechMedical Devices

Founders & leadership

RB
Robert BallCEO & Executive ChairmanBoard of Directors / Co-founder at Genesis Innovation Group
MA
Matthew AhearnChief Operating Officer
JP
Jeff PointsExecutive
DBDavid Blue
David BlueExecutive
DR
Don RunningManager and Chief Executive Officer
JO
Jeff OndrlaChief Technology OfficerBoard of Directors / Co-founder at Genesis Innovation Group

Board

GP
Geoff PardoBoard director
MCMike Carusi
Mike CarusiBoard directorManaging Partner at Lightstone Ventures
CTCasey Tansey
Casey TanseyBoard directorGeneral Partner at US Venture Partners
MD
Michael DeVriesManagerBoard Director at WMU Biosciences Research & Commercialization Center
PB
Paul BuckmanBoard director
KS
Kevin SidowBoard director

Investors · 9

APERTURE Venture PartnersBoston · $1M – $5M
Arboretum VenturesAnn Arbor · $5M – $15M
Genesis Innovation GroupGrand Rapids
Global BrainTokyo · $100K – $184M
Invest MichiganNorthville · $100K – $250K
Lightstone VenturesPortola Valleyvia Mike Carusi · board
US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board
Wakestream VenturesGrand Rapids · $150K – $500K
WMU Biosciences Research & Commercialization CenterKalamazoo · $100K – $250K

Reported raises · per SEC filings

Form D private placements

$85.5M disclosed across 8 rounds · 2015–2025

▶$20.1MraisedMar 2025 · 27 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoff PardoDirector
  • Jeff PointsExecutive Officer
  • Paul BuckmanDirector
  • Mike CarusiDirector
  • Kevin SidowDirector
  • Matthew AhearnExecutive Officer, Director
  • Casey TanseyDirector
  • Robert BallExecutive Officer, Director
  • David BlueExecutive Officer
Offering amount
$40.1M
Amount sold
$20.1M
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$32.2MraisedFeb 2023 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Casey TanseyDirector
  • Mike CarusiDirector
  • David BlueExecutive Officer
  • Kevin SidowDirector
  • Geoff PardoDirector
  • Paul BuckmanDirector
  • Robert BallExecutive Officer, Director
  • Matthew AhearnExecutive Officer, Director
Offering amount
$39.8M
Amount sold
$32.2M
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedOct 2022 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert BallExecutive Officer, Director
  • Mike CarusiDirector
  • David BlueExecutive Officer
  • Matthew AhearnExecutive Officer, Director
  • Paul BuckmanDirector
  • Kevin SidowDirector
  • Casey TanseyDirector
Offering amount
$7M
Amount sold
$3.5M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.6MraisedOct 2020 · 24 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew AhearnExecutive Officer, Director
  • Robert BallExecutive Officer, Director
  • David BlueExecutive Officer
  • Casey TanseyDirector
  • Mike CarusiDirector
  • Kevin SidowDirector
  • Paul BuckmanDirector
Offering amount
$21.6M
Amount sold
$21.6M
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedFeb 2020 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew AhearnExecutive Officer, Director
  • Robert BallExecutive Officer, Director
  • Ron FrisbieDirector
  • Kim PasquinoDirector
  • Stephen GuntherDirector
Offering amount
$2.2M
Amount sold
$2.2M
Minimum investment
$1.4K
First sale
Jan 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedNov 2018 · 27 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew AhearnExecutive Officer, Director
  • Stephen GuntherDirector
  • Robert BallExecutive Officer, Director
Offering amount
$5.6M
Amount sold
$5.1M
First sale
Feb 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$593.9KraisedMar 2016 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Don RunningDirector
  • Michael DeVriesDirector
  • Stephen B GuntherDirector
  • Robert BallDirector
Offering amount
$700K
Amount sold
$593.9K
First sale
Feb 2016
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$200KraisedMay 2015 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Don RunningExecutive Officer, Director
  • Jeff OndrlaExecutive Officer
  • Robert BallExecutive Officer, Director
  • Stephen GuntherDirector
  • Michael DeVriesDirector
Offering amount
$200K
Amount sold
$200K
Minimum investment
$200K
First sale
Apr 2015
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap
Read the Press Release92 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Vumedi62 shared keywordsVumedi operates a peer-to-peer video education platform where clinicians watch lectures and technique videos across dozens of medical specialties. It partners with academic institutions, hospitals, and life sciences companies to provide continuing medical education content to doctors.
Doximity42 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.

Companies competing with Shoulder Innovations for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Shoulder Innovations closes $50M credit facility refinancing By Investing.cominvesting.com · Jun 2026Shoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlookprnewswire.com · May 2026Shoulder Innovations Announces Closing of $40 Million Series Eshoulderinnovations.com · Mar 2025Shoulder Innovations Revenue Grows 380%, Closes $1.6 Million Investmentgenesisinnovationgroup.com · Dec 2017

Frequently asked questions

What does Shoulder Innovations do?
Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis. The company produces medical devices for orthopedic shoulder procedures.
Who are Shoulder Innovations's investors?
Shoulder Innovations's investors include APERTURE Venture Partners, Arboretum Ventures, Genesis Innovation Group, Global Brain, Invest Michigan, Lightstone Ventures, US Venture Partners, Wakestream Ventures and 1 more.
How much funding has Shoulder Innovations raised?
Shoulder Innovations has disclosed $85.5M raised across 8 rounds.
Where is Shoulder Innovations headquartered?
Shoulder Innovations is headquartered in Northern California, US.